118 related articles for article (PubMed ID: 2667598)
1. Pharmacological investigations of a new renin inhibitor in normal sodium-unrestricted volunteers.
de Gasparo M; Cumin F; Nussberger J; Guyenne TT; Wood JM; Menard J
Br J Clin Pharmacol; 1989 May; 27(5):587-96. PubMed ID: 2667598
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and biochemical consequences of renin inhibition by infusion of CGP 38560A in normal volunteers.
Nussberger J; Delabays A; De Gasparo M; Cumin F; Waeber B; Brunner HR; Ménard J
Hypertension; 1989 Jun; 13(6 Pt 2):948-53. PubMed ID: 2661435
[TBL] [Abstract][Full Text] [Related]
3. Plasma angiotensins, renin, and blood pressure during acute renin inhibition by CGP 38 560A in hypertensive patients.
Jeunemaître X; Ménard J; Nussberger J; Guyene TT; Brunner HR; Corvol P
Am J Hypertens; 1989 Nov; 2(11 Pt 1):819-27. PubMed ID: 2686709
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of three different potent renin inhibitors in primates.
Clozel JP; Fischli W
Hypertension; 1993 Jul; 22(1):9-17. PubMed ID: 8319997
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.
Azizi M; Ménard J; Bissery A; Guyenne TT; Bura-Rivière A; Vaidyanathan S; Camisasca RP
J Am Soc Nephrol; 2004 Dec; 15(12):3126-33. PubMed ID: 15579516
[TBL] [Abstract][Full Text] [Related]
6. Assays to measure nanomolar levels of the renin inhibitor CGP 38 560 in plasma.
Cumin F; de Gasparo M; Wood JM; Schnell C; Frueh F; Graf P
Hypertension; 1989 Oct; 14(4):379-84. PubMed ID: 2676860
[TBL] [Abstract][Full Text] [Related]
7. R-PEP-27, a potent renin inhibitor, decreases plasma angiotensin II and blood pressure in normal volunteers.
Zusman RM; Hui KY; Nussberger J; Christensen DM; Higgins J; Carlson WD; Schoenfeld D; Haber E
Am J Hypertens; 1994 Apr; 7(4 Pt 1):295-301. PubMed ID: 8031544
[TBL] [Abstract][Full Text] [Related]
8. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
Azizi M; Guyene TT; Chatellier G; Ménard J
J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
[TBL] [Abstract][Full Text] [Related]
10. Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humans.
Camenzind E; Nussberger J; Juillerat L; Munafo A; Fischli W; Coassolo P; van Brummelen P; Kleinbloesem CH; Waeber B; Brunner HR
J Cardiovasc Pharmacol; 1991 Sep; 18(3):299-307. PubMed ID: 1720828
[TBL] [Abstract][Full Text] [Related]
11. Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension.
van den Meiracker AH; Admiraal PJ; Man in 't Veld AJ; Derkx FH; Ritsema van Eck HJ; Mulder P; van Brummelen P; Schalekamp MA
BMJ; 1990 Jul; 301(6745):205-10. PubMed ID: 2203486
[TBL] [Abstract][Full Text] [Related]
12. Primacy of the renin-angiotensin system in mediating the aldosterone response to sodium restriction.
Swartz SL; Williams GH; Hollenberg NK; Dluhy RG; Moore TJ
J Clin Endocrinol Metab; 1980 Jun; 50(6):1071-4. PubMed ID: 6989849
[TBL] [Abstract][Full Text] [Related]
13. Expression of components of the RAS during prolonged blockade at different levels in primates.
Samani NJ; Cumin F; Kelly M; Wood JM
Am J Physiol; 1994 Oct; 267(4 Pt 1):E612-9. PubMed ID: 7943312
[TBL] [Abstract][Full Text] [Related]
14. Effects of renin inhibition in the conscious primate Macaca fascicularis.
Hui KY; Knight DR; Nussberger J; Hartley LH; Vatner SF; Haber E
Hypertension; 1989 Nov; 14(5):480-7. PubMed ID: 2680962
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the biochemical effects of renin inhibition in normal volunteers treated by an ACE inhibitor.
Chauveau D; Guyenne TT; Cumin F; Chatellier G; Corvol P; Ménard J
Br J Clin Pharmacol; 1992 Mar; 33(3):253-60. PubMed ID: 1315560
[TBL] [Abstract][Full Text] [Related]
16. Renin--angiotensin antagonists and the regulation of blood pressure.
Samuels AI; Miller ED; Fray JC; Haber E; Barger AC
Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095
[TBL] [Abstract][Full Text] [Related]
17. Adrenal responses to pharmacological interruption of the renin-angiotensin system in sodium-restricted normal man.
Williams GH; Hollenberg NK; Brown C; Mersey JH
J Clin Endocrinol Metab; 1978 Oct; 47(4):725-31. PubMed ID: 400731
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of renin and aldosterone during low-dose epinephrine infusion.
Kruse HJ; Kreutz R; Staib S; Overlack A; Stumpe KO; Kolloch RE
Am J Hypertens; 1994 Oct; 7(10 Pt 1):913-8. PubMed ID: 7826555
[TBL] [Abstract][Full Text] [Related]
19. beta-Endorphin stimulates plasma renin and aldosterone release in normal human subjects.
Rabinowe SL; Taylor T; Dluhy RG; Williams GH
J Clin Endocrinol Metab; 1985 Mar; 60(3):485-9. PubMed ID: 3156142
[TBL] [Abstract][Full Text] [Related]
20. A specific role for saline or the sodium ion in the regulation of renin and aldosterone secretion.
Tuck ML; Dluhy RG; Williams GH
J Clin Invest; 1974 Apr; 53(4):988-95. PubMed ID: 4360859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
